About the Journal
Volume 7, 2026
Online Edition: ISSN 2712-0082
Co-Editor-in-Chief: Pintong Huang
Professor
Zhejiang University, Hangzhou, China
Co-Editor-in-Chief: Chaozong Liu
Professor
University College London, London, United Kingdom
Executive Editor: Zhiwen Luo
Principal Investigator
Fudan Zhangjiang Institute, Fudan University, Shanghai, China
BIOI launched in 2020; previously published in 4 issues per volume, the journal has adopted a continuous article publication process from 2024. Volume 7 will publish in 2026.
Have you seen the #ProsTIC26 program? Register now to hear from leading local and international experts in real-world, case-based sessions covering the latest advances in #PSMA imaging and emerging #theranostics targets. Explore: http://prostic26.org/program
@DrMHofman @PeterMacCC
Theranostics is transforming nuclear medicine.
Hosted by @OECD_NEA & @ANSTO, the 1st Asia-Pacific Workshop on Medical Radioisotopes at @UNSW saw ARPANSA’s Dr Ivan Williams discuss how regulation can support innovation & deliver positive outcomes.
#Theranostics #NuclearMedicine
New Target on Tumor Blood Vessels Could Expand Immunotherapy Responses
LPL-positive tumor #bloodvessels identified that enhance T-cell infiltration into liver metastases, offering a new target to improve #cancerimmunotherapy
@DKFZ
#IPMoncology #Tcells
BIO Integration is indexed in EBSCO, EMBASE, Scopus, CAS, DOAJ, Research4Life, Ulrich’s web, OCLC, WorldCat, Primo Central (Ex Libris), Sherpa Romeo, CNKI Scholar (Chinese National Knowledge Infrastructure) and Summon Databases.
